Target intelligence / Profile preview

Cytochrome c pseudogene 34 (CYCSP34)

Target
CYCSP34
Molecular classification
Other (Pseudogene)
01

Overview

Cytochrome c pseudogene 34 (CYCSP34, also known as HCP34) is one of nearly 50 identified cytochrome c–related pseudogenes in the human genome[3]. Pseudogenes are genetic sequences similar to known genes but are considered nonfunctional due to disabling mutations, lack of expression, and/or truncation[2][3]. CYCSP34 is not expressed as a protein and shows features common to processed pseudogenes, such as absence of introns and frequent inactivating mutations. These pseudogenes do not participate in normal cytochrome c biological functions, such as electron transport or apoptosis, and are generally unrelated to disease or therapeutic intervention[2][3][6]. No evidence supports CYCSP34 as a therapeutic, diagnostic, or functional target. It should not be confused with the functional cytochrome c gene (CYCS), which plays important roles in mitochondrial electron transport and apoptosis[6]; only the functional CYCS gene product is therapeutically relevant. Overall, CYCSP34 is a non-coding, nonfunctional pseudogene with no current biomedical significance as a molecular target.

Other names
HCP34CYCS pseudogene 34
02

Mechanism of action

None (no protein product or active mechanism)

03

Biological functions

None (Does not encode a functional protein or play an active biological role)[3]
04

Disease associations

None directly; pseudogenes typically do not contribute to disease mechanisms[3]
05

Safety considerations

None (no known clinical impact as a pseudogene)
06

Interacting drugs

None (as it does not encode for a druggable protein or RNA product)
07

Biomarkers

None (not used as a clinical or research biomarker)

Beyond the preview

Go deeper on Cytochrome c pseudogene 34 (CYCSP34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c pseudogene 34 (CYCSP34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call